Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer’s disease neuropathology

27 May 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine and Purinergic Signaling
Share to Genetics and Neurodevelopmental Disorders
Share to Neurological Complications and Syndromes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18506388
DOI: 10.1007/s00702-008-0067-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer’s disease neuropathologyPMID 18506388Read ↗

Loss of P2Y2 Nucleotide Receptors Enhances Early Pathology in the TgCRND8 Mouse Model of Alzheimer's DiseaseSemantic proximity Read ↗

Hippocampal purinergic P2X7 receptor level is increased in Alzheimer’s disease patients, and associated with amyloid and tau pathologiesSemantic proximity Read ↗

Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's diseaseSemantic proximity Read ↗

Reduced Expression of the Inhibitory Synapse Scaffolding Protein Gephyrin in Alzheimer's DiseaseSemantic proximity Read ↗

P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer’s disease modelSemantic proximity Read ↗

Increased RyR2 open probability induces neuronal hyperactivity and memory loss with or without Alzheimer's disease-causing gene mutations.Semantic proximity Read ↗

Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.Semantic proximity Read ↗

Expression of nicotinic acetylcholine receptors in Alzheimer’s disease: postmortem investigations and experimental approachesSemantic proximity Read ↗

Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.Semantic proximity Read ↗

The P2X7 receptor: a new therapeutic target in Alzheimer’s diseaseSemantic proximity Read ↗

Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's diseaseSemantic proximity Read ↗

The extracellular ATP/P2X7R signaling axis drives early neuroinflammation and neuronal hyperexcitability in an Alzheimer’s disease mouse modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.